GlassScriptPhysician profile
Leslie K Partlow
NPI 1194216994
$4,989.89
in general payments reported to CMS, 2019-2025
19 companies · $1,332 in 2025
The $1,332 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,010 · 2022: $654 · 2023: $1,190 · 2024: $804 · 2025: $1,332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,590 · Travel and Lodging: $646 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,590.01 |
| Travel and Lodging | $645.84 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,041.11 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Abbott Laboratories | $745.62 | 2021-2025 | Eterna |
| Saluda Medical Americas, INC. | $575.37 | 2022-2024 | Evoke Scs, Evoke |
| Nevro Corp. | $554.07 | 2022-2024 | Senza |
| Relievant Medsystems, INC. | $187.68 | 2022 | |
| Globus Medical, INC. | $160.35 | 2025 | Senza |
| Biohaven Pharmaceuticals, INC. | $137.15 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $117.95 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $93.06 | 2025 | Relistor |
| Impel Pharmaceuticals INC. | $68.40 | 2023 | Trudhesa |
| Abbvie INC. | $62.82 | 2022-2025 | |
| Tersera Therapeutics LLC | $61.84 | 2022-2023 | Prialt |
| Boston Scientific Corporation | $55.83 | 2022-2025 | General - Pain Management |
| Vertex Pharmaceuticals Incorporated | $25.04 | 2025 | |
| Allergan, INC. | $24.76 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $24.59 | 2024 | Durolane |
| Biohaven Pharmaceutical Holding Company LTD. | $19.20 | 2022 | |
| Pfizer INC. | $18.08 | 2023 | |
| Curonix LLC | $16.97 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Partlow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.